Rhythm Pharmaceuticals, Inc. (RYTM) stock
RYTMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 5/30249% above fair value
$109.86−2.30 (-2.05%)
Close on Nov 12, 2026Market cap $7.56BP/E –Yield –
Rhythm Pharmaceuticals statistics
80 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Feb 25, 2027 (estimated, before the open)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jun 30, 2026
- Share price as of
- Nov 12, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 77.11
- 2.29
Enterprise valuationIndustry
- EV / Sales
- 30.59
- 2.60
Share statisticsIndustry
- Shares Change (YoY)
- 8.08%
- 10.9%
- Shares Change (QoQ)
- 0.54%
- 0.51%
- Float
- 68M
- 49M
- Shares Held by Insiders
- 1.06%
- 12.1%
- Shares Held by Institutions
- 112.4%
- 56.4%
Short sellingIndustry
- Short Interest
- 12M
- –
- Short Interest Change
- 6.11%
- -0.76%
- Short % of Float
- 17.1%
- 9.04%
- Short % of Shares Outstanding
- 17.0%
- 6.30%
- Days to Cover
- 23.33
- 5.13
Stock price statisticsIndustry
- 52-Week High
- $122.20
- –
- 52-Week Low
- $74.50
- –
- 20-Day Moving Average
- $97.52
- –
- 50-Day Moving Average
- $96.68
- –
- 200-Day Moving Average
- $97.19
- –
- Average True Range (14)
- $5.17
- –
- Price Change (1 Week)
- 4.61%
- 1.51%
- Price Change (1 Month)
- 26.7%
- -2.35%
- Price Change (3 Months)
- -4.87%
- -21.1%
- Price Change (6 Months)
- 17.3%
- -22.6%
- Price Change (YTD)
- 2.63%
- -22.6%
- Price Change (1 Year)
- 10.0%
- -20.7%
- Price Change (3 Years)
- 283.6%
- -27.4%
- Price Change (5 Years)
- 734.2%
- -77.3%
- Average Volume (10 Days)
- 3M
- –
- Average Volume (20 Days)
- 2M
- –
- Average Volume (90 Days)
- 906,756
- –
- Relative Volume
- 1.18
- 0.79
- Relative Strength Index (14)
- 62.1
- 44.7
- Volatility (1 Year)
- 54.3%
- 80.4%
- Beta (5 Years)
- 1.40
- 1.07
MarginsIndustry
- Pretax Margin
- -85.1%
- -11.8%
- EBITDA Margin
- -83.6%
- -27.7%
Returns on capitalIndustry
- Return on Equity (ROE)
- -450.9%
- -51.2%
- Return on Assets (ROA)
- -50.7%
- -40.6%
- Return on Capital Employed (ROCE)
- -64.0%
- -38.0%
Financial positionIndustry
- Current Ratio
- 3.45
- 3.30
- Quick Ratio
- 3.00
- 2.42
- Debt / Equity
- 1.03
- 0.49
- Interest Coverage
- -10.86
- -6.35
GrowthIndustry
- Revenue Growth (YoY)
- 53.5%
- 7.01%
- Revenue Growth (3Y CAGR)
- 100.2%
- 2.25%
EfficiencyIndustry
- Asset Turnover
- 0.59
- 0.40
- Inventory Turnover
- 1.07
- 2.73
- Revenue Per Employee
- $579.51K
- $429.29K
- Profits Per Employee
- -$496.01K
- -$683.67K
- Employee Count
- 414
- 75
- WACC
- 12.0%
- 10.1%
Income statement (TTM)Industry
- Pretax Income
- -$204.28M
- -$13.23M
Balance sheetIndustry
- Net Cash (Debt)
- $224.80M
- $17.46M
- Net Cash Per Share
- $3.26
- $0.72
- Equity (Book Value)
- $102.98M
- $53.27M
- Book Value Per Share
- $1.50
- $1.50
- Tangible Book Value
- $98.09M
- $26.82M
- Working Capital
- $302.98M
- $79.47M
Cash flow (TTM)Industry
Dividends and yieldsIndustry
- Earnings Yield
- -2.71%
- -20.8%
Taxes and interestIndustry
- Interest Expense
- $18.48M
- $2.93M
- Income Tax
- $1.07M
- $74.00K
Scores and fair valueIndustry
- Altman Z-Score
- 15.83
- 0.30
- Piotroski F-Score
- 6
- 4
- Beneish M-Score
- -2.89
- -2.62
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | RYTM | S&P 500 | Difference | RYTM per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +22.3% | -2.7% | +25.0 pts | ||
| 3 months | -6.6% | -1.7% | −4.8 pts | ||
| Year to date | +2.6% | +11.9% | −9.3 pts | ||
| 1 year | +12.2% | +12.0% | +0.2 pts | ||
| 3 years | +286.0% | +78.2% | +207.8 pts | +56.9% | +21.2% |
| 5 years | +734.2% | +73.2% | +660.9 pts | +52.8% | +11.6% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
12M RYTM shares were sold short on Oct 30, 2026, up 6.1% from the previous report, or 17.14% of the shares available to trade. At recent volumes it would take 23.3 days to buy them back. Over the last 20 sessions, 58.8% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 11,675,496 | +6.1% | 500,502 | 23.3 |
| Oct 15, 2026 | 11,003,490 | +2.2% | 816,276 | 13.5 |
| Sep 30, 2026 | 10,767,698 | +4.7% | 761,706 | 14.1 |
| Sep 15, 2026 | 10,287,811 | -0.1% | 512,774 | 20.1 |
| Aug 31, 2026 | 10,303,031 | +1.5% | 470,672 | 21.9 |
| Aug 14, 2026 | 10,154,327 | +7.6% | 829,841 | 12.2 |
| Jul 31, 2026 | 9,440,417 | -1.4% | 583,684 | 16.2 |
| Jul 15, 2026 | 9,574,527 | -0.9% | 696,954 | 13.7 |
| Jun 30, 2026 | 9,665,089 | +20.7% | 1,275,960 | 7.6 |
| Jun 15, 2026 | 8,005,303 | +1.2% | 691,418 | 11.6 |
| May 29, 2026 | 7,911,004 | -4.5% | 535,388 | 14.8 |
| May 15, 2026 | 8,282,367 | +2.8% | 1,000,436 | 8.3 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?